We worked with a pan-European trade association to excite stakeholders across Europe around ways to improve cancer outcomes and realise the value of new cancer medicines.   Through 12 EU and national roundtables, we engaged more than 150 cancer experts across 10 different European countries. We captured their insights in a White Paper securing endorsement from leading European cancer organisations. The programme inspired further initiatives by national associations to ensure continued action at national level across Europe.